Potential Utility of Sodium Selenate as an Adjunct to Metformin in Treating Type II Diabetes Mellitus in Rats: A Perspective on Protein Tyrosine Phosphatase

<table>Glucose tolerance curve showing the effect of glucose (2 g/kg, p.o) in normal control, nontreated DIR, and treated rats with metformin, sodium selenate and their combination. Values represent the mean of 6 rats ± SEM (one-way ANOVA followed by LSD test). DIR: diabetic/insulin resistant, DIR + Met: diabetic/insulin resistant + metformin, DIR + Sel: diabetic/insulin resistant + sodium selenate, DIR + Met + Sel: diabetic/insulin resistant + metformin + sodium selenite.</table>

BioMed Research International

fig1

Figure 1

Figure 1: Potential Utility of Sodium Selenate as an Adjunct to Metformin in Treating Type II Diabetes Mellitus in Rats: A Perspective on Protein Tyrosine Phosphatase 

Figure 1 | Potential Utility of Sodium Selenate as an Adjunct to Metformin in Treating Type II Diabetes Mellitus in Rats: A Perspective on Protein Tyrosine Phosphatase 